Corvus Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $768K, a 43% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.58M, a 11.6% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.15M, a 20.2% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.69M, a 36.4% decline from 2021.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.23M, a 26.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.58M $768K +$231K +43% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.34M $689K +$197K +40% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.15M $572K -$48K -7.74% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $2.2M $546K -$112K -17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.31M $537K -$138K -20.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $2.45M $492K -$247K -33.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $2.69M $620K -$118K -16% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $2.81M $658K -$438K -40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.25M $675K -$498K -42.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.75M $739K -$486K -39.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $4.23M $738K -$498K -40.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 $4.73M $1.1M -$187K -14.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $4.92M $1.17M -$210K -15.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $5.13M $1.23M -$620K -33.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.75M $1.24M -$512K -29.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $6.26M $1.28M -$466K -26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $6.73M $1.38M -$515K -27.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $7.24M $1.85M -$108K -5.53% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $7.35M $1.75M -$56K -3.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $7.4M $1.75M -$45K -2.51% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $7.45M $1.9M +$162K +9.33% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $7.29M $1.95M +$152K +8.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $7.14M $1.8M +$65K +3.74% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 $7.07M $1.79M +$293K +19.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $6.78M $1.74M +$215K +14.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $6.56M $1.8M +$333K +22.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $6.23M $1.74M +$691K +65.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 $5.54M $1.5M +$237K +18.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $5.3M $1.52M +$446K +41.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $4.86M $1.47M +$1.03M +233% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $3.83M $1.05M +$762K +266% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $3.07M $1.26M +$1.14M +928% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $1.93M $1.08M +$1.06M +6224% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $867K $441K +$439K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $428K $286K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $123K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $17K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2K* Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.